Trial intelligence / Profile preview

Dexmedetomidine vs Morphine for Analgesia in Bariatric Surgery

NCT02213159Phase 3Completed

Sponsor
American University of Beirut Medical Center
Start
Jul 2014
Primary completion
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by American University of Beirut Medical Center. Primary endpoint: Total dose of morphine consumed in Post Anesthesia Care Unit (PACU). Started Jul 2014; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02213159.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02213159.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call